Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

835 ARTÍCULOS , VIENDO DEL 601 AL 615

Safety and efficacy of individualised exercise and NAD(+) precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial

Lin KY, Bucha A, McSweeney K, Wade KL, Karaj A, Tamaroff J, O'Malley S, Chung NM, Cilenti NA, Wanner J, Adzika GK, Mesaros C, Blair IA, Rojsajjakul T, Serai S, Farmer J, Bryant K, Lu Y, Harhay MO, Weber DR, Paridon SM, Seifert EL, Putt ME, Zamani P, Baur JA, Lynch DR, McCormack SE.

Lancet Neurol. 2026 May;25(5):469-481. doi: 10.1016/S1474-4422(26)00082-7.

Systematic review of hematopoietic stem cell transplantation in patients with ataxia telangiectasia: a case report and an individual patient-level analysis

Bekis Bozkurt H, Spaccamela VM, Hassan M, Felber M, Zeilhofer U, Zeckanovic A, Bourquin JP, Jacquier D, Ceppi F, Candotti F, Güngör T.

Front Immunol. 2026 Apr 13;17:1754093. doi: 10.3389/fimmu.2026.1754093. eCollection 2026.

Malignancies in the context of Inborn errors of immunity: an immunologist's view

Genc Ozbay Z, Soyak Aytekin E, Esenboga S, Cagdas D.

Expert Rev Clin Immunol. 2026 Feb;22(2):223-231. doi: 10.1080/1744666X.2026.2633137. Epub 2026 Feb 22.

Distal arthrogryposis with impaired proprioception and touch: description of 9 additional cases harbouring novel PIEZO2 variants and literature review

Diodato D, Bosco L, Catteruccia M, Sancesario A, Jofrè J, Suarez B, Lacaux P, Tosi M, De Luca G, Mizzoni I, Pro S, Bellacchio E, Fattori F, Novelli A, Bertini E, Castiglioni C, D'Amico A.

Eur J Paediatr Neurol. 2026 Mar;61:24-35. doi: 10.1016/j.ejpn.2026.01.003. Epub 2026 Feb 21.

Movement disorders due to primary central nervous system lymphoma: An illustrative case and systematic literature review

Harlay V, Mira V, Petrirena G, Bertucci A, Tabouret E, Schenone L, Grimaldi S.

Rev Neurol (Paris). 2026 Apr;182(4):248-258. doi: 10.1016/j.neurol.2026.02.152. Epub 2026 Mar 3.

Unraveling Riboflavin-Mediated Mitochondrial Modulation as a Therapeutic Pathway in Neurological Disorders: An Integrative Systematic Review

Silva-Araújo ER, Toscano AE, Cavalcanti Bezerra Gouveia HJ, Pontes PB, Dos Santos-Júnior JP, Dos Santos-Júnior OH, Teixeira Beltrão de Lemos MD, de Oliveira Melo NC, Viana de Melo J, Padrón-Hernández E, Manhães-de-Castro R.

J Nutr. 2026 Feb 18:101427. doi: 10.1016/j.tjnut.2026.101427. Online ahead of print.

Ataxia telangiectasia mutated (ATM) kinase as a predictive biomarker in clinical oncology: implications for a precision treatment approach

Pham AT, Yuan F, Nagathihalli NS, Dosch AR.

Neoplasia. 2026 Jul;77:101309. doi: 10.1016/j.neo.2026.101309. Epub 2026 Apr 22.

Molecular Determinants of Response and Rational Drug Combinations for Antibody-Drug Conjugates (ADCs) with Topoisomerase I (TOP1) Inhibitor Payloads

Pommier Y.

J Mol Biol. 2026 Aug 15;438(16):169841. doi: 10.1016/j.jmb.2026.169841. Epub 2026 May 4.

Spinocerebellar Ataxia Type 35 Presenting with Dysphagia in a Patient from Saudi Arabia: A Case Report and Literature Review

Attar A, Abduhamid AS, Halabi MH, Bahalaq A, Sibyani A, Ejaz Ahmed M, Aladdin Y.

Cerebellum. 2026 Feb 4;25(1):14. doi: 10.1007/s12311-025-01947-3.

Anti-GQ1b Antibody Syndrome: A Clinician-Oriented Perspective on Diagnostics, Therapy, and Atypical Phenotypes-With an Illustrative 16-Case Institutional Series

Bannai T, Yamada M, Seki T, Shiio Y, Yamasoba T.

J Clin Med. 2026 Jan 19;15(2):801. doi: 10.3390/jcm15020801.

Spinocerebellar ataxia with mixed tremor and hippocampal atrophy: case report and literature review

Wang X, Zhou B, Guo Z, Shao W.

Front Neurosci. 2026 Feb 24;20:1741827. doi: 10.3389/fnins.2026.1741827. eCollection 2026.

Perceptual and Acoustical Features of Dysarthria in Essential Tremor: An Observational Study that Expands the Cerebellar Features of Essential Tremor

Ghosh N, Hernandez N, Wainman E, Forestieri I, Louis ED, Lester-Smith RA.

Tremor Other Hyperkinet Mov (N Y). 2026 May 6;16:30. doi: 10.5334/tohm.1180. eCollection 2026.

Sialidosis type I: How to alleviate disabling myoclonic seizures?-A multicenter analysis of eight cases and review of the literature

Gburek-Augustat J, Lee IC, Rubino M, Topçu V, Chavez-Castillo M, Tu SC, Shinawi M, Alfradique-Dunham I, Valtcheva M, Adarmes-Gómez A, Macias-Garcia D, Laura Muñoz-Delgado L, Jesús S, Mir P, Merkenschlager A, Coppola A.

Epilepsia Open. 2026 Apr;11(2):577-591. doi: 10.1002/epi4.70233. Epub 2026 Feb 10.

Beyond 100 years of vitamin E and related molecules - Milestones and open challenges

Maria WW, Jeffrey A, Angelo A, Desirée B, Marc B, Werner B, Lisa B, Consuelo B, Joan M CM, Manfred E, Jan F, Alissa C G, Qing J, Jacquelyn D L, Sijia L, Stefan L, Danny M, Anna M, Christina M, Etsuo N, Noriko N, Ute OJ, Nesrin K O, Szabolcs P, Maren P, Erdi S, Maret G T, José V, Brigitte WR, Jean-Marc Z, Francesco G.

Mol Aspects Med. 2026 Jun;109:101477. doi: 10.1016/j.mam.2026.101477. Epub 2026 May 6.

Phase 1 study of ceralasertib, an ATR kinase inhibitor, in combination with durvalumab in patients with recurrent or metastatic NSCLC or HNSCC

Lopez JS, Harrington KJ, Im SA, Lee KW, Postel-Vinay S, Thomas JS, Lukashchuk N, Willis SE, Irurzun-Arana I, Webb B, Nehra J, Lau A, Loembé AB, Dean E, Krebs MG.

Br J Cancer. 2026 Jun;134(11):1568-1579. doi: 10.1038/s41416-026-03408-y. Epub 2026 Mar 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias